<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  6     ADVERSE REACTIONS<BR>               <BR>               <BR>                  The following serious adverse reactions can occur with Tasigna and are discussed in greater detail in other sections of the package insert [<BR>                     s<BR>                     ee <BR>                     Boxed Warning<BR>                     , <BR>                     Warnings and Precautions (5)<BR>                     ]<BR>                     .<BR>                  <BR>                  Myelosuppression [see Warnings and Precautions (5.1)]<BR>                  <BR>                  QT prolongation [<BR>                     s<BR>                     ee Boxed Warning, Warnings and Precautions<BR>                      <BR>                     (5.2)]<BR>                  <BR>                  Sudden deaths [see Boxed Warning, Warnings and Precautions (5.3<BR>                     )<BR>                     ]<BR>                  <BR>                  Elevated serum lipase [<BR>                     s<BR>                     ee Warnings and Precautions (5.<BR>                     4<BR>                     )<BR>                     ]<BR>                  <BR>                  Hepatotoxicity [<BR>                     s<BR>                     ee Warnings and Precautions (5.<BR>                     5<BR>                     )<BR>                     ]<BR>                  <BR>                  Electrolyte abnormalities [<BR>                     s<BR>                     ee <BR>                     Boxed Warning<BR>                     , <BR>                     Warnings and Precautions (5.6)<BR>                     ]<BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        The most commonly reported non-hematologic adverse reactions (≥10%) in patients with newly diagnosed Ph+ CML-CP, resistant or intolerant <BR>                        Ph+ CML-CP, or resistant or intolerant Ph+ CML-AP were rash, pruritus, headache, nausea, fatigue, myalgia, nasopharyngitis, constipation, diarrhea, abdominal pain, vomiting, arthralgia, pyrexia, upper respiratory tract infection, back pain, cough, and asthenia. Hematologic adverse drug reactions include myelosuppression: thrombocytopenia, neutropenia and anemia. (6.1)<BR>                        <BR>                           <BR>                              <BR><BR>                              <BR>To report SUSPECTED ADVERSE REACTIONS, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.1     Clinical Trials Experience<BR>                     <BR>                        Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.<BR>                        <BR>                           In Patients with Newly Diagnosed Ph+ CML-CP<BR>                        <BR>                        The data below reflect exposure to Tasigna from a randomized trial in patients with newly diagnosed Ph+ CML in chronic phase treated at the recommended dose of 300 mg twice daily (n=279). The median time on treatment in the nilotinib 300 mg twice daily group was 36.4 months (range 0.1 – 46.7 months). The median actual dose intensity was 594 mg/day in the nilotinib 300 mg twice daily group.<BR>                        The most common (>10%) non-hematologic adverse drug reactions were rash, pruritus, headache, nausea, fatigue and myalgia. Upper abdominal pain, alopecia, constipation, diarrhea, dry skin, muscle spasms, arthralgia, abdominal pain, peripheral edema, vomiting, pain in extremity, dyspepsia, and asthenia were observed less commonly (≤10% and >5%) and have been of mild to moderate severity, manageable and generally did not require dose reduction. Pleural and pericardial effusions, occurred in 1% and <1% of patients, respectively. Gastrointestinal hemorrhage was reported in 2.5% of patients.<BR>                        Increase in QTcF >60 msec from baseline was observed in 1 patient (0.4%) in the 300 mg twice daily treatment group. No patient had an absolute QTcF of >500 msec while on study drug.<BR>                        The most common hematologic adverse drug reactions (all grades) were myelosuppression including: thrombocytopenia (18%), neutropenia (15%) and anemia (7%). See Table 7 for Grade 3/4 laboratory abnormalities.<BR>                        Discontinuation due to adverse reactions, regardless of relationship to study drug, was observed in 10% of patients.<BR>                        <BR>                           In Patients with Resistant or Intolerant Ph+ CML-CP and CML-AP<BR>                        <BR>                        In the single open-label multicenter clinical trial, a total of 458 patients with Ph+ CML-CP and CML-AP resistant to or intolerant to at least one prior therapy including imatinib were treated (CML-CP=321; CML-AP=137) at the recommended dose of 400 mg twice daily.<BR>                        The median duration of exposure in days for CML-CP and CML-AP patients is 561 (range 1-1096) and 264 (range 2-1160), respectively. The median dose intensity for patients with CML-CP and CML-AP is 789 mg/day (range 151–1110) and 780 mg/day (range 150-1149), respectively and corresponded to the planned 400 mg twice daily dosing.<BR>                        The median cumulative duration in days of dose interruptions for the CML-CP patients was 20 (range 1-345), and the median duration in days of dose interruptions for the CML-AP patients was 23 (range 1–234).<BR>                        In patients with CML-CP, the most commonly reported non-hematologic adverse drug reactions (≥10%) were rash, pruritus, nausea, fatigue, headache, constipation, diarrhea, vomiting and myalgia. The common serious drug-related adverse reactions (≥1% and <10%) were thrombocytopenia, neutropenia and anemia.<BR>                        In patients with CML-AP, the most commonly reported non-hematologic adverse drug reactions (≥10%) were rash, pruritus and fatigue. The common serious adverse drug reactions (≥1% and <10%) were thrombocytopenia, neutropenia, febrile neutropenia, pneumonia, leukopenia, intracranial hemorrhage, elevated lipase and pyrexia.<BR>                        Sudden deaths and QT prolongation were reported. The maximum mean QTcF change from baseline at steady-state was 10 msec. Increase in QTcF >60 msec from baseline was observed in 4.1% of the patients and QTcF of >500 msec was observed in 4 patients (<1%) [<BR>                           s<BR>                           ee Boxed Warning<BR>                           , <BR>                           Warnings and Precautions (5.2<BR>                           ,<BR>                            5.3<BR>                           ),<BR>                            Clinical Pharmacology (12.4)<BR>                           ].<BR>                        Discontinuation due to adverse drug reactions was observed in 16% of CML-CP and 10% of CML-AP patients. <BR>                        <BR>                           Most Frequently Reported Adverse <BR>                           Reactions<BR>                        <BR>                        Tables 5 and 6 show the percentage of patients experiencing non-hematologic adverse reactions (excluding laboratory abnormalities) regardless of relationship to study drug. Adverse reactions reported in greater than 10% of patients who received at least one dose of Tasigna are listed. <BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><BR>                           <caption>Table 5:&#160;Most Frequently Reported Non-hematologic Adverse Reactions (Regardless of Relationship to Study Drug) in Patients with Newly Diagnosed Ph+ CML-CP (&#8805;10% in Tasigna 300 mg twice daily or Imatinib 400 mg once daily groups) 36-Month Analysis<sup>a</sup><BR>                           </caption><BR>                           <col width="237"/><BR>                           <col width="150"/><BR>                           <col width="123"/><BR>                           <col width="137"/><BR>                           <col width="136"/><BR>                           <col width="137"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="4" align="center"><BR>                                    <content styleCode="bold">Patients with Newly Diagnosed Ph+ CML-CP</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Lrule Rrule " colspan="4" align="center"/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">TASIGNA</content><BR>                                    <br/><BR>                                    <content styleCode="bold">300 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">twice</content><BR>                                    <br/><BR>                                    <content styleCode="bold">daily</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">Imatinib</content><BR>                                    <br/><BR>                                    <content styleCode="bold">400 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">once</content><BR>                                    <br/><BR>                                    <content styleCode="bold">daily</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">TASIGNA</content><BR>                                    <br/><BR>                                    <content styleCode="bold">300 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">twice</content><BR>                                    <br/><BR>                                    <content styleCode="bold">daily</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">Imatinib</content><BR>                                    <br/><BR>                                    <content styleCode="bold">400 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">once</content><BR>                                    <br/><BR>                                    <content styleCode="bold">daily</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">N=279</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">N=280</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">N=279</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">N=280</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2"><BR>                                    <content styleCode="bold">Body System and Preferred Term</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">All Grades</content><BR>                                    <content styleCode="bold"> (%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">CTC Grades</content><BR>                                    <content styleCode="bold"><BR>                                       <sup>b</sup><BR>                                    </content><BR>                                    <content styleCode="bold"> 3 / 4 (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Skin and subcutaneous tissue disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Rash</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">38</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pruritus</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">21</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Alopecia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Dry skin</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Gastrointestinal disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nausea</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">21</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">40</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Constipation</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Diarrhea</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">16</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">44</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Vomiting</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">25</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Abdominal pain upper</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">17</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Abdominal pain </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Dyspepsia </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">8</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nervous system disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Headache</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">30</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">20</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Dizziness</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">General disorders and administration site conditions</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Fatigue</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">22</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">17</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pyrexia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Asthenia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Peripheral edema</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">20</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Face edema</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Musculoskeletal and connective tissue disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Myalgia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Arthralgia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Muscle spasms</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">33</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pain in extremity</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Back pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Respiratory, thoracic and mediastinal disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Cough</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Oropharyngeal pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Infections and infestations</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nasopharyngitis</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">24</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">19</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Upper respiratory tract infection</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Influenza</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">8</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Eye disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Eyelid edema</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Periorbital edema</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Psychiatric disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Insomnia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR>                           a Excluding laboratory abnormalities<BR><BR>                           b NCI Common Terminology Criteria for Adverse Events, Version 3.0<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><BR>                           <caption>Table 6:&#160;Most Frequently Reported Non-hematologic Adverse Reactions in&#160;Patients with&#160;Resistant or Intolerant Ph+ CML Receiving Tasigna 400 mg Twice Daily&#160;(Regardless of Relationship to Study Drug) (&#8805;10% in any Group) 24-Month Analysis<sup>a</sup><BR>                           </caption><BR>                           <col width="235"/><BR>                           <col width="156"/><BR>                           <col width="146"/><BR>                           <col width="146"/><BR>                           <col width="146"/><BR>                           <col width="146"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2"><BR>                                    <content styleCode="bold">Body System and Preferred Term</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">CML-CP</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">CML-AP</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">N=321</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">N=</content><BR>                                    <content styleCode="bold">137</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule " colspan="2"/><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">All Grades (%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">CTC Grades</content><BR>                                    <content styleCode="bold"><BR>                                       <sup>b  </sup><BR>                                    </content><BR>                                    <content styleCode="bold">3 / 4 (%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">All Grades (%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">CTC Grades</content><BR>                                    <content styleCode="bold"><BR>                                       <sup>b  </sup><BR>                                    </content><BR>                                    <content styleCode="bold">3 / 4 (%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Skin and subcutaneous tissue disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Rash</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">36</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">29</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pruritus</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">32</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">20</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Night sweat</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">27</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Alopecia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Gastrointestinal disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nausea</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">37</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">22</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Constipation</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">26</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">19</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Diarrhea</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">28</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">24</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Vomiting</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">29</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Abdominal pain </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">16</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Abdominal pain upper</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Dyspepsia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nervous system disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Headache</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">35</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">20</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">General disorders and administration site conditions</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Fatigue</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">32</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">23</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pyrexia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">22</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">28</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Asthenia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">16</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Peripheral edema</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Myalgia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">19</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">16</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Musculoskeletal and connective tissue disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Arthralgia&#160;</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">26</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">16</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Muscle spasms</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">13</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Bone pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">14</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Pain in extremity</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">20</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Back pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">17</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Musculoskeletal pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Respiratory, thoracic and mediastinal disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Cough</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">27</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Dyspnea</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Oropharyngeal pain</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Infections and infestations</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Nasopharyngitis</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">24</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule ">Upper respiratory tract infection</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Metabolism and nutrition disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Decreased appetite*</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">17</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Psychiatric disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Insomnia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Vascular disorders</td><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hypertension</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR><BR>                           a Excluding laboratory abnormalities    b NCI Common Terminology Criteria for Adverse Events, Version 3.0  c Also includes preferred term anorexia<BR>                        <BR>                           Laboratory Abnormalities<BR>                        <BR>                        Table 7 shows the percentage of patients experiencing treatment-emergent Grade 3/4 laboratory abnormalities in patients who received at least one dose of Tasigna.<BR>                        <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><BR>                           <caption>Table 7:&#160;Percent Incidence of Clinically Relevant Grade 3/4* Laboratory Abnormalities</caption><BR>                           <col width="206"/><BR>                           <col width="133"/><BR>                           <col width="133"/><BR>                           <col width="133"/><BR>                           <col width="133"/><BR>                           <tbody><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="4" align="center"><BR>                                    <content styleCode="bold">Patient Population</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">Newly </content><BR>                                    <content styleCode="bold">D</content><BR>                                    <content styleCode="bold">iagnosed Ph+ CML-CP</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " colspan="2" align="center"><BR>                                    <content styleCode="bold">Resistant or </content><BR>                                    <content styleCode="bold">I</content><BR>                                    <content styleCode="bold">ntolerant Ph+</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule "/><BR>                                 <td styleCode="Lrule Rrule " colspan="2" align="center"/><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">CML-CP</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">CML-AP</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">TASIGNA 300 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">twice daily</content><BR>                                    <br/><BR>                                    <content styleCode="bold">N=279</content><BR>                                    <br/><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">Imatinib</content><BR>                                    <content styleCode="bold"> 400 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">once daily</content><BR>                                    <br/><BR>                                    <content styleCode="bold">N=280</content><BR>                                    <br/><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">TASIGNA 400 mg </content><BR>                                    <br/><BR>                                    <content styleCode="bold">twice daily</content><BR>                                    <br/><BR>                                    <content styleCode="bold">N=3</content><BR>                                    <content styleCode="bold">21</content><BR>                                    <br/><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center"><BR>                                    <content styleCode="bold">TASIGNA 400 mg</content><BR>                                    <br/><BR>                                    <content styleCode="bold">twice daily</content><BR>                                    <br/><BR>                                    <content styleCode="bold">N=1</content><BR>                                    <content styleCode="bold">37</content><BR>                                    <br/><BR>                                    <content styleCode="bold">(%)</content><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "><BR>                                    <content styleCode="bold">Hematologic Parameters</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Thrombocytopenia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">10</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">30<sup>1</sup><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">42<sup>3</sup><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Neutropenia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">21</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">31<sup>2</sup><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">42<sup>4</sup><BR>                                 </td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Anemia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">11</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">27</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule "><BR>                                    <content styleCode="bold">Biochemistry Parameters</content><BR>                                 </td><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                                 <td styleCode="Toprule Lrule Rrule "/><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated lipase</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">8</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">18</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hyperglycemia </td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">12</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hypophosphatemia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">17</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">15</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated bilirubin (total)</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated SGPT (ALT)</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hyperkalemia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">6</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hyponatremia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">7</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hypokalemia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">9</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated SGOT (AST)</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Decreased albumin</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">4</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">3</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Hypocalcemia</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">2</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">5</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated alkaline phosphatase</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">1</td><BR>                              </tr><BR>                              <tr><BR>                                 <td styleCode="Toprule Lrule Rrule ">Elevated creatinine</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">0</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                                 <td styleCode="Toprule Lrule Rrule " align="center">&lt;1</td><BR>                              </tr><BR>                           </tbody><BR>                        </table><BR>                        <BR><BR><BR>*NCI Common Terminology Criteria for Adverse Events, version 3.0<BR>                        <BR>                           1CML-CP: Thrombocytopenia:  12% were grade 3, 18% were grade 4<BR>                        <BR>                           2CML-CP: Neutropenia:  16% were grade 3, 15% were grade 4<BR>                        <BR>                           3CML-AP: Thrombocytopenia:  11% were grade 3, 32% were grade 4<BR>                        <BR>                           4CML-AP:  Neutropenia:  16% were grade 3, 26% were grade 4 <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     6.2     Additional Data from Clinical Trials<BR>                     <BR>                        The following adverse drug reactions were reported in patients in the Tasigna clinical studies at the recommended doses. These adverse drug reactions are ranked under a heading of frequency, the most frequent first using the following convention: common (≥1% and <10%), uncommon (≥0.1% and <1%), and unknown frequency (single events). For laboratory abnormalities, very common events (≥10%), which were not included in Tables 5 and 6, are also reported. These adverse reactions are included based on clinical relevance and ranked in order of decreasing seriousness within each category.<BR>                        <BR>                           Infections and Infestations: Common: folliculitis, upper respiratory tract infection (including pharyngitis, nasopharyngitis, rhinitis). Uncommon: pneumonia, bronchitis, urinary tract infection, candidiasis (including oral candidiasis), gastroenteritis. Unknown frequency: sepsis, subcutaneous abscess, anal abscess, furuncle, tinea pedis.<BR>                        <BR>                           Neoplasm<BR>                           s Benign<BR>                           , Malignant and Unspecif<BR>                           i<BR>                           ed: Common: Skin papilloma. Unknown frequency: oral papilloma, paraproteinemia.<BR>                        <BR>                           Blood and Lymphatic System Disorders: Common: febrile neutropenia, pancytopenia, lymphopenia. Unknown frequency: thrombocythemia, leukocytosis, eosinophilia.<BR>                        <BR>                           Immune System Disorders: Unknown frequency: hypersensitivity.<BR>                        <BR>                           Endocrine Disorders: Uncommon: hyperthyroidism, hypothyroidism. Unknown frequency:  hyperparathyroidism secondary, thyroiditis.<BR>                        <BR>                           Metabolism and Nutrition Disorders: Very Common: hypophosphatemia. Common: electrolyte imbalance (including hypomagnesemia, hyperkalemia, hypokalemia, hyponatremia, hypocalcemia, hypercalcemia, hyperphosphatemia), diabetes mellitus, hyperglycemia, hypercholesterolemia, hyperlipidemia. Uncommon: gout, dehydration, increased appetite. Unknown frequency: hyperuricemia, hypoglycemia, dyslipidemia.<BR>                        <BR>                           Psychiatric Disorders: Common: depression, insomnia, anxiety. Unknown frequency: disorientation, confusional state, amnesia, dysphoria.<BR>                        <BR>                           Nervous System Disorders: Common: dizziness, peripheral neuropathy, hypoesthesia, paresthesia. Uncommon: intracranial hemorrhage, migraine, loss of consciousness (including syncope), tremor, disturbance in attention, hyperesthesia. Unknown frequency: brain edema, optic neuritis, lethargy, dysesthesia, restless legs syndrome. <BR>                        <BR>                           Eye Disorders: Common: eye hemorrhage, periorbital edema, eye pruritus, conjunctivitis, dry eye (including xerophthalmia). Uncommon: vision impairment, vision blurred, visual acuity reduced, photopsia, hyperemia (scleral, conjunctival, ocular), eye irritation, conjunctival hemorrhage. Unknown frequency: papilloedema, diplopia, photophobia, eye swelling, blepharitis, eye pain, chorioretinopathy, conjunctivitis allergic, ocular surface disease.<BR>                        <BR>                           Ear and Labyrinth Disorders: Common: vertigo. Unknown frequency: hearing impaired, ear pain, tinnitus.<BR>                        <BR>                           Cardiac Disorders: Common: angina pectoris, arrhythmia (including atrioventricular block, cardiac flutter, extrasystoles, atrial fibrillation, tachycardia, bradycardia), palpitations, electrocardiogram QT prolonged. Uncommon: cardiac failure, pericardial effusion, coronary artery disease, cyanosis, cardiac murmur. Unknown frequency: myocardial infarction, ventricular dysfunction, pericarditis, ejection fraction decrease. <BR>                        <BR>                           Vascular Disorders: Common: hypertension, flushing. Uncommon: hypertensive crisis, peripheral arterial occlusive disease, hematoma. Unknown frequency:  shock hemorrhagic, hypotension, thrombosis, arteriosclerosis.<BR>                        <BR>                           Respiratory, Thoracic and Mediastinal Disorders: Common: dyspnea, dyspnea exertional, epistaxis, cough, dysphonia. Uncommon: pulmonary edema, pleural effusion, interstitial lung disease, pleuritic pain, pleurisy, pharyngolaryngeal pain, throat irritation. Unknown frequency: pulmonary hypertension, wheezing, oropharyngeal pain.<BR>                        <BR>                           Gastrointestinal Disorders: Common: pancreatitis, abdominal discomfort, abdominal distension, dyspepsia, dysgeusia, flatulence. Uncommon: gastrointestinal hemorrhage, melena, mouth ulceration, gastroesophageal reflux, stomatitis, esophageal pain, dry mouth, sensitivity of teeth. Unknown frequency: gastrointestinal ulcer perforation, retroperitoneal hemorrhage, hematemesis, gastric ulcer, esophagitis ulcerative, subileus, gastritis, enterocolitis, hemorrhoids, hiatus hernia, rectal hemorrhage, gingivitis.<BR>                        <BR>                           Hepatobiliary Disorders: Very Common: hyperbilirubnemia. Common: hepatic function abnormal. Uncommon: hepatotoxicity, toxic hepatitis, jaundice. Unknown frequency: cholestasis, hepatomegaly.<BR>                        <BR>                           Skin and Subcutaneous Tissue Disorders:  Common: night sweats, eczema, urticaria, erythema, hyperhidrosis, contusion, acne, dermatitis (including allergic, exfoliative and acneiform), dry skin. Uncommon: exfoliative rash, drug eruption, pain of skin, ecchymosis, swelling of face. Unknown frequency: psoriasis, erythema multiforme, erythema nodosum, skin ulcer, palmar-plantar erythrodysesthesia syndrome, petechiae, photosensitivity, blister, dermal cyst, sebaceous hyperplasia, skin atrophy, skin discoloration, skin exfoliation, skin hyperpigmentation, skin hypertrophy, hyperkeratosis. <BR>                        <BR>                           Musculoskeletal and Connective Tissue Disorders: Common: bone pain, musculoskeletal chest pain, musculoskeletal pain, back pain, neck pain, flank pain. Uncommon: musculoskeletal stiffness, muscular weakness, joint swelling. Unknown frequency: arthritis.<BR>                        <BR>                           Renal and Urinary Disorders: Common: pollakiuria. Uncommon: dysuria, micturition urgency, nocturia. Unknown frequency: renal failure, hematuria, urinary incontinence, chromaturia.<BR>                        <BR>                           Reproductive System and Breast Disorders: Uncommon: breast pain, gynecomastia, erectile dysfunction. Unknown frequency: breast induration, menorrhagia, nipple swelling.<BR>                        <BR>                           General Disorders and Administration Site Conditions: Common: pyrexia, chest pain (including non-cardiac chest pain), pain, chest discomfort, malaise.  Uncommon: face edema, gravitational edema, influenza-like illness, chills, feeling body temperature change (including feeling hot, feeling cold). Unknown frequency: localized edema.<BR>                        <BR>                           Investigations: Very Common: alanine aminotransferase increased, aspartate aminotransferase increased, lipase increased. Common: hemoglobin decreased, blood amylase increased, gamma-glutamyltransferase increased, blood creatinine phosphokinase increased, blood alkaline phosphatase increased, weight decreased, weight increased. Uncommon: blood lactate dehydrogenase increased, blood urea increased, globulins decreased. Unknown frequency: troponin increased, blood bilirubin unconjugated increased, blood insulin increased, blood insulin decreased, insulin C-peptide decreased, lipoprotein increased (including very low density and high density), blood parathyroid hormone increased.<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>